0001787518 false 00000 00-0000000 CN 0001787518 2022-02-24 2022-02-24 0001787518 BRLI:UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember 2022-02-24 2022-02-24 0001787518 BRLI:OrdinarySharesNoParValuePerShareMember 2022-02-24 2022-02-24 0001787518 BRLI:RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember 2022-02-24 2022-02-24 0001787518 BRLI:WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember 2022-02-24 2022-02-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 24, 2022

 

BRILLIANT ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

 

British Virgin Islands   001-39341   N/A
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

99 Dan Ba Road, C-9, Putuo District,

Shanghai, Peoples Republic of China

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (86) 021-80125497

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on 
which registered
         
Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant   BRLIU   The Nasdaq Stock Market LLC
         
Ordinary Shares, no par value per share   BRLI   The Nasdaq Stock Market LLC
         
Rights, each right entitling the holder to 1/10 of one Ordinary Share   BRLIR   The Nasdaq Stock Market LLC
         
Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share   BRLIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of Brian Ferrier as Director

 

On February 24, 2022, the Board of Directors (the “Board”) of Brilliant Acquisition Corporation (the “Company”) appointed Brian Ferrier to fill a vacancy on, and serve as a member of, the Board, with immediate effect, until such time as he resigns or is removed and his successor appointed. There is no arrangement or understanding between Mr. Ferrier and the Company or any other person pursuant to which he was elected as a director. Mr. Ferrier will serve as a member of the Audit Committee of the Board and the Compensation Committee of the Board.

 

There are no related party transactions involving Mr. Ferrier that are reportable under Item 404(a) of Regulation S-K. There are no material plans, contracts or arrangements to which Mr. Ferrier is a party or in which he would participate being entered into in connection with his appointment as a director of the Board.

 

Appointment of Yebo Shen as Director

 

On February 24, 2022, the Board appointed Yebo Shen to fill a vacancy on, and serve as a member of, the Board, with immediate effect, until such time as he resigns or is removed and his successor appointed. There is no arrangement or understanding between Mr. Shen and the Company or any other person pursuant to which he was elected as a director. Mr. Shen will serve as a member of the Audit Committee and Chair of the Compensation Committee of the Board.

 

There are no related party transactions involving Mr. Shen that are reportable under Item 404(a) of Regulation S-K. There are no material plans, contracts or arrangements to which Mr. Shen is a party or in which he would participate being entered into in connection with his appointment as a director of the Board.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BRILLIANT ACQUISITION CORPORATION
     
  By:  /s/ Dr. Peng Jiang
    Name: Dr. Peng Jiang
    Title: Chief Executive Officer
     
Dated: February 28, 2022    

 

2